1st Quarter - Report

CAPITOL HILL CONSULTING GROUP for NOVARTIS CORPORATION

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

General healthcare issues related to pharmaceutical and biological products; Federal Food, Drug, and Cosmetic Act (21 USC 9); Public Health Service Act (42 USC 6A); follow-on biologics; America's Affordable Health Choices Act (H.R. 3200); Affordable Healthcare for America Act (H.R. 3962); Patient Protection and Affordable Act (H.R. 3590)

LobbyistCovered position, as disclosed
BILL K BREWSTER —
STEVEN E IRIZARRY —
DAVID JORY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3590 (111th), H.R. 3200 (111th), H.R. 3962 (111th)

Medicare/Medicaid MMM

General Medicare and Medicaid issues, including but not limited to, coverage and reimbursement; Physician Payments Sunshine Act (S.301)

LobbyistCovered position, as disclosed
BILL K BREWSTER —
STEVEN E IRIZARRY —
DAVID JORY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 301 (111th)

Budget/Appropriations BUD

FDA funding issues, generally, FY2010 Labor-HHS Appropriations; FY2010 Supplemental Appropriations;; Pandemic vaccine issues; American Recovery and Reinvestment Act (H.R. 1)

LobbyistCovered position, as disclosed
BILL K BREWSTER —
STEVEN E IRIZARRY —
DAVID JORY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1 (111th)

Government Issues GOV

General Patent Issues

LobbyistCovered position, as disclosed
BILL K BREWSTER —
STEVEN E IRIZARRY —
DAVID JORY —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.